The European Pharmacopoeia has revised its guidance on alternative microbiological methods, introducing clearer provisions for validation and implementation. The recent EDQM symposium in Strasbourg provides an opportunity to examine the implications for pharmaceutical quality control laboratories.

Mentre negli Stati Uniti la governance dei sistemi più avanzati punta anche sull’autoregolazione dei produttori, FDA ed EMA costruiscono un quadro diverso per il life sciences: rischio, context of use, tracciabilità, verifica delle prestazioni e controllo lungo l’intero ciclo di vita.

A novelty in the world of biomaterials

Genenta announces Long-Term follow-up observations in brain tumor (GBM) study with emerging survival signals

Special issue of MakingPharmaIndustry Magazine, published for CPHI 2026, the leading event for the pharmaceutical industry.

The October issue of the MakingPharmaIndustry tabloid accompanies CPHI Milan 2026, exploring ATMPs, biotech, manufacturing, analytics, engineering and the technologies transforming the pharmaceutical industry.